drugset / Trial / NCT01627431

Residual Platelet Activity In Advanced Peripheral Artery Disease

NCT01627431 ↗

NaSingle-groupOpen-labelBasic science

Summary

The peripheral arterial disease (PAD) is a common atherosclerotic disease manifestation and its prevalence increase with age and with the simultaneous presence of cardiovascular risk factors. PAD patients are usually treated, as a first line treatment, with the exercise therapy, combined with the pharmacological antiplatelet therapy. In the case of first line therapy failure, PAD patients usually undergoing to invasive revascularization procedures. After a peripheral stent has been located, the major follow-up problem is the restenosis rate. Published studies describe how, in a large amount of patients, can be recognised an high residual platelet activity. These data about PAD patients at the moment are lacking . The authors would evaluate the incidence of PAD patients with an high residual platelet activity.

Timeline

Start
2012-07
Primary completion
2014-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Background Aspirin Small molecule 100 mg —
Background Clopidogrel Small molecule 75 mg —